Decimate-C Anticancer Foundation
About Decimate-C Anticancer Foundation
Data last updated:
Decimate-C Anticancer Foundation is a private not for profit company based in Pune, Maharashtra, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 27 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2012NPL145805. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rhucha Rahul Dasare and Prerana Prasad Patil.
Its last annual general meeting (AGM) was held on 21 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.03 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹2.17 Lakh (net margin -27%) and EBITDA of -₹2.01 Lakh (EBITDA margin -25%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No. 8 4th Floor Amit Complex Opp – New English School Tilak Road Sadashiv, Peth, Pune, Maharashtra, India – 411030
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Auditor Details of Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation is audited by J H MEDHI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J H MEDHI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rhucha Rahul Dasare | Director | 18 Dec 2019 | 6 Years 9 Months | Current |
| Prerana Prasad Patil | Director | 18 Dec 2019 | 6 Years 9 Months | Current |
| Arundhati Anil Ranade | Director | 17 Jan 2017 | 9 Years 8 Months | Current |
Financials of Decimate-C Anticancer Foundation FY 2025 filings available
Decimate-C Anticancer Foundation reported revenue of ₹8.03 Lakh (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Decimate-C Anticancer Foundation
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 65% fall in the latest year. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Decimate-C Anticancer Foundation
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.01 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.17 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Decimate-C Anticancer Foundation
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -27% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Decimate-C Anticancer Foundation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Decimate-C Anticancer Foundation
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Decimate-C Anticancer Foundation
Employment history and EPFO contributions of people linked to Decimate-C Anticancer Foundation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Decimate-C Anticancer Foundation
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Decimate-C Anticancer Foundation
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Decimate-C Anticancer Foundation
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Decimate-C Anticancer Foundation
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Decimate-C Anticancer Foundation
Frequently Asked Questions about Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation is an active private not for profit company based in Pune, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 27 December 2012 (14+ years old) and is registered under CIN U85100PN2012NPL145805.
Decimate-C Anticancer Foundation reported revenue of ₹8.03 Lakh for FY 2025 (down 65% YoY).
Decimate-C Anticancer Foundation has 3 current directors:
- Rhucha Rahul Dasare - Director
- Prerana Prasad Patil - Director
- Arundhati Anil Ranade - Director
Decimate-C Anticancer Foundation reported a net loss of ₹2.17 Lakh (net margin -27%) and EBITDA of -₹2.01 Lakh (EBITDA margin -25%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Decimate-C Anticancer Foundation is -25% over three years and -23% over five years. In the latest year (FY 2025) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
No. Decimate-C Anticancer Foundation has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Decimate-C Anticancer Foundation is U85100PN2012NPL145805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decimate-C Anticancer Foundation was incorporated on 27 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
The registered office of Decimate-C Anticancer Foundation is at Office No. 8 4th Floor Amit Complex Opp – New English School Tilak Road Sadashiv, Peth, Pune, Maharashtra, India – 411030.